We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.66%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
+$44.3M
(+31%)
Cap. Flow
+$55.2M
Cap. Flow
% of AUM
29.71%
Top 10 Holdings %
Top 10 Hldgs %
58.03%
Holding
319
New
65
Increased
26
Reduced
45
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$9.83M |
| 2 |
Alibaba
BABA
|
+$2.05M |
| 3 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$1.48M |
| 4 |
Plains GP Holdings
PAGP
|
+$934K |
| 5 |
ESPR
Esperion Therapeutics
ESPR
|
+$918K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualys
QLYS
|
+$931K |
| 2 |
RAX
Rackspace Hosting Inc
RAX
|
+$814K |
| 3 |
RKUS
RUCKUS WIRELESS INC COM STK (DE)
RKUS
|
+$735K |
| 4 |
DTO
DB Crude Oil Double Short Exchange Traded Notes due June 1, 2038
DTO
|
+$712K |
| 5 |
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$712K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.2% |
| 2 | Financials | 30.88% |
| 3 | Healthcare | 9.98% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Energy | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bank of America
BAC
$428B
| $45.2M | 24.31% |
2,524,548
| – | – |
|
2
CALL
Johnson & Johnson
JNJ
$640B
| $2.61M | 1.41% |
25,000
| – | – |
|
|
HEOP
3
DELISTED
Heritage Oaks Bancorp
HEOP
| $2.31M | 1.24% |
275,000
| – | – |
|
|
DENN
4
DELISTED
Denny's
DENN
| $2.27M | 1.22% |
220,000
-40,000
| -15% | -$355K |
|
|
5
Alibaba
BABA
$279B
| $2.08M | 1.12% |
+20,000
| New | +$2.05M |
|
|
ARIA
6
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $2.01M | 1.08% |
292,200
+20,000
| +7% | +$125K |
|
|
LTS
7
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $1.72M | 0.92% |
435,000
-40,000
| -8% | -$158K |
|
|
8
CALL
Alibaba
BABA
$279B
| $1.56M | 0.84% |
+15,000
| New | +$1.54M |
|
9
CALL
United States Oil Fund
USO
$2.03B
| $1.53M | 0.82% |
+9,375
| New | +$2.08M |
|
|
HES
10
DELISTED
Hess
HES
| $1.49M | 0.8% |
20,200
+10,000
| +98% | +$792K |
|
|
TARO
11
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.48M | 0.8% |
10,000
-1,000
| -9% | -$147K |
|
12
CALL
McDonald's
MCD
$184B
| $1.41M | 0.76% |
15,000
-5,000
| -25% | -$468K |
|
|
FSGI
13
DELISTED
FIRST SECURITY GROUP, INC.
FSGI
| $1.36M | 0.73% |
600,000
| – | – |
|
14
Acadia Pharmaceuticals
ACAD
$5.12B
| $1.3M | 0.7% |
41,000
-10,000
| -20% | -$284K |
|
15
Columbia Banking Systems
COLB
$8.68B
| $1.27M | 0.68% |
46,000
| – | – |
|
|
ESPR
16
DELISTED
Esperion Therapeutics
ESPR
| $1.21M | 0.65% |
+30,000
| New | +$918K |
|
17
Par Pacific Holdings
PARR
$3.86B
| $1.15M | 0.62% |
70,982
+7,500
| +12% | +$115K |
|
|
CLR
18
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.15M | 0.62% |
+30,000
| New | +$1.48M |
|
|
GM.WS.B
19
DELISTED
General Motors Company
GM.WS.B
| $1.11M | 0.6% |
65,107
-46,180
| -41% | -$667K |
|
|
NPSP
20
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $1.07M | 0.58% |
30,000
+5,000
| +20% | +$149K |
|
21
Loews
L
$22.5B
| $1.05M | 0.57% |
25,000
| – | – |
|
|
FARM
22
DELISTED
Farmer Brothers
FARM
| $1.04M | 0.56% |
35,500
| – | – |
|
23
Alnylam Pharmaceuticals
ALNY
$31.7B
| $1.02M | 0.55% |
10,500
-2,000
| -16% | -$185K |
|
24
CALL
ExxonMobil
XOM
$643B
| $925K | 0.5% |
10,000
| – | – |
|
|
25
Plains GP Holdings
PAGP
$5.55B
| $899K | 0.48% |
+13,143
| New | +$934K |
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q4 2014 Portfolio in Review
As of Q4 2014, E.E. Geduld held 319 positions worth $186M, up 31% from $142M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
E.E. Geduld deployed $55.2M of net new capital in Q4 2014, opening 65 new positions and adding to 26 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 25,000 shares worth $81K.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was General Motors Company, an estimated $667K trimmed.
- E.E. Geduld's largest Q4 2014 buy was Regeneron Pharmaceuticals: 25,000 shares worth $81K.
- E.E. Geduld added most to Hess in Q4 2014, an estimated $792K increase.
- E.E. Geduld's biggest Q4 2014 reduction was General Motors Company, cutting an estimated $667K.
- E.E. Geduld fully exited Qualys in Q4 2014, selling an estimated $931K.
- E.E. Geduld's ten largest holdings make up 58% of its $186M portfolio in Q4 2014.
- E.E. Geduld opened 65 new positions and closed 58 in Q4 2014.
- E.E. Geduld's portfolio value rose 31% quarter-over-quarter to $186M.
Based on E.E. Geduld's 13F filing for Q4 2014, filed 30 Jan 2015.